IP Library › Granted Patent US 12,591,781
Granted Patent B2
US 12,591,781 · App. 17/786,878 · Granted Mar 31, 2026

Methods and systems for determining optimal decision time related to embryonic implantation

Inventor: Itay Erlich (Mevo Horon, IL)
Assignee: FAIRTILITY LTD.
G06N3/084G06F18/24133G06N3/045G06N7/01G06T7/0012G06V10/82G06V20/69G06V20/698G16H50/20A61B17/435A61D19/00G06T2207/30044
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,591,781
App. No.
17/786,878
Granted
Mar 31, 2026
Kind
B2
Abstract

Methods and systems are for improvements to in-vitro fertilization using morpho-kinetic signatures. These improvements are achieved by analyzing a series of images of a developing embryo (e.g., time-lapse images) as opposed to a single static image. For example, due to the difficulty in identifying clear distinctions between morphological states based on static images, as well as the unpredictability of morpho-kinetic development of an embryo, the system analyzes the development of an embryo as a whole over a given time frame (e.g., fertilization to blastulation), which provides a better prediction of the viability of a given embryo. The analysis may take the form of a morpho-kinetic signature, which itself may be used to determine an optimal time to transfer and/or implant an embryo into a patient.

Claims (70)

1 . A method of determining an optimal decision time related to embryonic implantation, the method comprising:

receiving, using control circuitry, a first morpho-kinetic signature of a first embryo, wherein the first morpho-kinetic signature is a representation of morpho-kinetic events in the first embryo as a function of time;

labeling, using the control circuitry, the first morpho-kinetic signature with a known time of peak implantation;

training, using the control circuitry, an artificial neural network to detect the known time of peak implantation based on the first morpho-kinetic signature;

receiving, using the control circuitry, a second morpho-kinetic signature of a second embryo with an unknown time of peak implantation, wherein the second morpho-kinetic signature is a representation of morpho-kinetic events in the second embryo as a function of time;

inputting, using the control circuitry, the second morpho-kinetic signature into the trained artificial neural network; and

receiving, using the control circuitry, a prediction from the trained artificial neural network that the second morpho-kinetic signature corresponds to the known time of peak implantation.

2 . The method of claim 1 , wherein the known time of peak implantation corresponds to a time when a probability of success of implantation is highest.

3 . The method of claim 1 , further comprising labeling the first morpho-kinetic signature with a known endometrial thickness, wherein the artificial neural network to is trained to detect the known time of peak implantation based on the first morpho-kinetic signature and the known endometrial thickness.

4 . The method of claim 1 , further comprising labeling the first morpho-kinetic signature with known clinical data, wherein the artificial neural network to is trained to detect the known time of peak implantation based on the first morpho-kinetic signature and the known clinical data.

5 . The method of claim 1 , further comprising:

receiving a first output from an initial artificial neural network indicating that the first embryo has a first classification at a first time point;

receiving a second output from the initial artificial neural network indicating the first embryo has a second classification at a second time point; and

aggregating the first output and second output to generate the first morpho-kinetic signature.

6 . The method of claim 1 , further comprising:

determining a first probability of successful implantation for the second embryo based on the prediction;

determining a second probability of successful implantation for a third embryo; and

determining a composite probability of success for implanting both the second embryo and the third embryo based on the first probability and the second probability.

7 . The method of claim 1 , further comprising:

determining a first probability of successful implantation for the second embryo based on the prediction;

determining a second probability of successful implantation for a third embryo;

normalizing the first probability and the second probability; and

selecting the second embryo based on the normalized first probability being higher than the normalized second probability.

8 . The method of claim 1 , wherein each morpho-kinetic event of the morpho-kinetic events is represented as a float value in a vector.

9 . The method of claim 1 , wherein the first morpho-kinetic signature is based on a series of time-lapse images of the morpho-kinetic events in the first embryo.

10 . The method of claim 9 , wherein the time of peak implantation corresponds to a time when a probability of success of implantation is highest.

11 . A method of determining an optimal decision time related to embryonic implantation, the method comprising:

receiving, using control circuitry, a morpho-kinetic signature of an embryo with an unknown time of peak implantation, wherein the morpho-kinetic signature is a representation of morpho-kinetic events in the embryo as a function of time;

inputting, using the control circuitry, the morpho-kinetic signature into an artificial neural network, wherein the artificial neural network is trained to detect to a time of peak implantation for the morpho-kinetic signature based on a set of training data comprising morpho-kinetic signatures labeled with known times of peak implantation;

receiving, using the control circuitry, a prediction, from the artificial neural network, for the time of peak implantation for the morpho-kinetic signature.

12 . The method of claim 11 , further comprising controlling a time-lapse imaging system to generate time-lapse images of the embryo and the morpho-kinetic signature is contained in the time-lapse images.

13 . The method of claim 11 , further comprising controlling an imaging system to generate z-stack images of the embryo and the morpho-kinetic signature is contained in the z-stack images.

14 . The method of claim 11 , further comprising controlling an imaging system to generate images of the embryo at multiple angles and the morpho-kinetic signature is contained in the images.

15 . A non-transitory computer-readable media comprising instructions that, when executed by one or more processors, cause operations comprising:

receiving a first morpho-kinetic signature of a first embryo, wherein the first morpho-kinetic signature is a representation of morpho-kinetic events in the first embryo as a function of time;

labeling the first morpho-kinetic signature with a known time of peak implantation;

training an artificial neural network to detect the known time of peak implantation based on the first morpho-kinetic signature;

receiving a second morpho-kinetic signature of a second embryo with an unknown time of peak implantation, wherein the second morpho-kinetic signature is a representation of morpho-kinetic events in the second embryo as a function of time;

inputting the second morpho-kinetic signature into the trained artificial neural network; and

receiving a prediction from the trained artificial neural network that the second morpho-kinetic signature corresponds to the known time of peak implantation.

16 . The non-transitory computer-readable media of claim 15 , wherein the known time of peak implantation corresponds to a time when a probability of success of implantation is highest.

17 . The non-transitory computer-readable media of claim 15 , wherein the instructions further cause operations comprising labeling the first morpho-kinetic signature with a known endometrial thickness, wherein the artificial neural network to is trained to detect the known time of peak implantation based on the first morpho-kinetic signature and the known endometrial thickness.

18 . The non-transitory computer-readable media of claim 15 , wherein the instructions further cause operations comprising labeling the first morpho-kinetic signature with known clinical data, wherein the artificial neural network to is trained to detect the known time of peak implantation based on the first morpho-kinetic signature and the known clinical data.

19 . The non-transitory computer-readable media of claim 15 , wherein the instructions further cause operations comprising:

receiving a first output from an initial artificial neural network indicating that the first embryo has a first classification at a first time point;

receiving a second output from the initial artificial neural network indicating the first embryo has a second classification at a second time point; and

aggregating the first output and second output to generate the first morpho-kinetic signature.

20 . The non-transitory computer-readable media of claim 15 , wherein the instructions further cause operations comprising:

determining a first probability of successful implantation for the second embryo based on the prediction;

determining a second probability of successful implantation for a third embryo; and

determining a composite probability of success for implanting both the second embryo and the third embryo based on the first probability and the second probability.

21 . The non-transitory computer-readable media of claim 15 , wherein the instructions further cause operations comprising:

determining a first probability of successful implantation for the second embryo based on the prediction;

determining a second probability of successful implantation for a third embryo;

normalizing the first probability and the second probability; and

selecting the second embryo based on the normalized first probability being higher than the normalized second probability.

22 . The non-transitory computer-readable media of claim 15 , wherein each morpho-kinetic event of the morpho-kinetic events is represented as a float value in a vector.

23 . The non-transitory computer-readable media of claim 15 , wherein the first morpho-kinetic signature is based on a series of time-lapse images of the morpho-kinetic events in the first embryo.

24 . The non-transitory computer-readable media of claim 15 , the operations further comprising:

generating pixel arrays from color images of the first morpho-kinetic signature, the pixel arrays comprising color components of the color images;

converting the pixel arrays from the color components to a grayscale representation; and

training the artificial neural network further based on the grayscale representation of the morpho-kinetic events.

25 . The non-transitory computer-readable media of claim 15 , the operations further comprising:

generating pixel arrays from grayscale images of the first morpho-kinetic signature;

converting the pixel arrays from grayscale pixels to color a color representation; and

training the artificial neural network further based on the color representation of the morpho-kinetic events.

26 . The non-transitory computer-readable media of claim 15 , the operations further comprising:

generating pixel arrays from images of the first morpho-kinetic signature;

adding an additional vector that includes clinical or demographic data related to the first embryo; and

training the artificial neural network further based on the pixel arrays of the morpho-kinetic events and also based on the additional vector.

Assignments (2)
SECURITY INTEREST Recorded Aug 3, 2023
From: FAIRTILITY LTD
To: KREOS CAPITAL VII AGGREGATOR SCSP
Reel/Frame 064476/0986 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2022
From: ERLICH, ITAY
To: FAIRTILITY LTD.
Reel/Frame 060238/0349 →
Continuity (3)
Provisional Application 63036612 · Jun 9, 2020
Provisional Application 62963795 · Jan 21, 2020
Related Publication 20230018456A1 · Jan 19, 2023
References Cited (22)
US 10510143B1 · Zhou et al. · 2019 [cited by applicant]
US 10942170B2 · Tan · 2021 [cited by examiner]
US 20100331611A1 · Konje · 2010 [cited by examiner]
US 20140087415A1 · Ramsing · 2014 [cited by examiner]
US 20140128667A1 · Ramsing · 2014 [cited by examiner]
US 20140220618A1 · Wirks et al. · 2014 [cited by applicant]
US 20140349334A1 · Chavez · 2014 [cited by applicant]
US 20150268227A1 · Tan · 2015 [cited by examiner]
US 20160078275A1 · Wang · 2016 [cited by examiner]
US 20200320708A1 · Ma · 2020 [cited by examiner]
US 20210249135A1 · Rimestad · 2021 [cited by examiner]
US 20210390697A1 · Marder Gilboa · 2021 [cited by applicant]
US 20220392062A1 · Chavez Badiola · 2022 [cited by examiner]
WO 2019068073A1 · 2019 [cited by applicant]
WO 2020001914A1 · 2020 [cited by applicant]
WO 2020058931A1 · 2020 [cited by applicant]
Lau et al. 2019, “Embryo staging with weakly-supervised region selection and dynamically-decoded predictions,” https://doi.org/10.48550/arXiv.1904.04419. [cited by examiner]
Silva-Rodríguez et al. 2019, “Predicting the Success of Blastocyst Implantation from Morphokinetic Parameters Estimated through CNNs and Sum of Absolute Differences,” 2019 27th European Signal Processing Conference (EUS… [cited by examiner]
International Preliminary Report on Patentability and Written Opinion issued in PCT Patent Application No. PCT/IB/050420, dated Aug. 4, 2022. [cited by applicant]
International Preliminary Report on Patentability and Written Opinion issued in PCT Patent Application No. PCT/IB/050421, dated Aug. 4, 2022. [cited by applicant]
International Search Report and Written Opinion issued in PCT Patent Application No. PCT/IB2021/050421, dated May 21, 2021. [cited by applicant]
Non-Final Office Action issued in U.S. Appl. No. 17/785,311, dated Sep. 18, 2024. [cited by applicant]